Capital Research Global Investors grew its position in shares of Morgan Stanley (NYSE:MS – Free Report) by 44.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,794,873 shares of the financial services provider’s stock after purchasing an additional 6,744,333 shares during the period. Capital Research Global Investors’ holdings in Morgan Stanley were worth $2,740,051,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Peoples Bank KS bought a new position in Morgan Stanley during the fourth quarter valued at approximately $25,000. IAG Wealth Partners LLC purchased a new stake in shares of Morgan Stanley in the 4th quarter valued at $28,000. Curio Wealth LLC bought a new position in shares of Morgan Stanley during the 4th quarter valued at $31,000. Crowley Wealth Management Inc. purchased a new position in Morgan Stanley in the 4th quarter worth $34,000. Finally, Stonebridge Financial Group LLC bought a new stake in Morgan Stanley in the fourth quarter worth $35,000. 84.19% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Morgan Stanley
In other news, CFO Raja Akram sold 17,500 shares of the stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $136.01, for a total transaction of $2,380,175.00. Following the sale, the chief financial officer now owns 81,440 shares in the company, valued at $11,076,654.40. This represents a 17.69 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Eric F. Grossman sold 13,097 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $136.20, for a total value of $1,783,811.40. Following the completion of the transaction, the insider now directly owns 197,444 shares in the company, valued at $26,891,872.80. This trade represents a 6.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 40,665 shares of company stock valued at $5,288,079 in the last ninety days. 0.24% of the stock is currently owned by corporate insiders.
Morgan Stanley Stock Performance
Morgan Stanley (NYSE:MS – Get Free Report) last announced its quarterly earnings data on Friday, April 11th. The financial services provider reported $2.60 EPS for the quarter, beating the consensus estimate of $2.21 by $0.39. The business had revenue of $17.74 billion during the quarter, compared to analyst estimates of $16.81 billion. Morgan Stanley had a return on equity of 14.39% and a net margin of 12.48%. The company’s revenue for the quarter was up 17.2% on a year-over-year basis. During the same quarter last year, the firm posted $2.02 earnings per share. As a group, analysts expect that Morgan Stanley will post 8.56 earnings per share for the current fiscal year.
Morgan Stanley Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Wednesday, April 30th will be issued a dividend of $0.925 per share. The ex-dividend date is Wednesday, April 30th. This represents a $3.70 annualized dividend and a dividend yield of 3.39%. Morgan Stanley’s payout ratio is 43.43%.
Analysts Set New Price Targets
Several research analysts have recently commented on MS shares. JPMorgan Chase & Co. decreased their price objective on Morgan Stanley from $125.00 to $122.00 and set a “neutral” rating on the stock in a report on Monday, April 14th. Bank of America decreased their price target on Morgan Stanley from $150.00 to $144.00 and set a “buy” rating on the stock in a research note on Wednesday, April 2nd. UBS Group increased their price objective on Morgan Stanley from $130.00 to $140.00 and gave the company a “neutral” rating in a research note on Tuesday, January 21st. Keefe, Bruyette & Woods lifted their target price on shares of Morgan Stanley from $138.00 to $145.00 and gave the stock a “market perform” rating in a research note on Friday, January 17th. Finally, Citigroup dropped their price target on shares of Morgan Stanley from $135.00 to $125.00 and set a “neutral” rating for the company in a research report on Monday, March 24th. Twelve research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $130.50.
Read Our Latest Analysis on Morgan Stanley
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Further Reading
- Five stocks we like better than Morgan Stanley
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- AppLovin: Can Record Profits Overcome Market Skepticism?
- The Risks of Owning Bonds
- MarketBeat Week in Review – 04/14 – 04/18
- What is an Earnings Surprise?
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.